Zoetis, Inc. (ZTS)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Kristin C. Peck
Employees:
13,800
10 SYLVAN WAY, PARSIPPANY, NJ 07054
973-822-7000

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts.

Data derived from most recent annual or quarterly report
Market Cap 87.126 Billion Shares Outstanding471.97 Million Avg 30-day Volume 1.518 Million
P/E Ratio35.124 Dividend Yield0.8354 EPS1.13
Price to Revenue9.5667 Debt to Equity1.2917 EBITDA3.604 Billion
Price to Book Value15.7705 Operating Margin35.8739 Enterprise Value84.879 Billion
Current Ratio3.869 EPS Growth0.121 Quick Ratio1.873
1 Yr BETA 0.9897 52-week High/Low 194.52 / 139.49 Profit Margin27.2011
Operating Cash Flow Growth18.7568 Free Cash Flow to Firm (FCFF) TTM 1.22 Billion Free Cash Flow to Equity (FCFE) TTM4.379 Billion
Altman Z-Score8.0422
Earnings Report2024-02-13
View SEC Filings from ZTS instead.

View recent insider trading info

Funds Holding ZTS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ZTS

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2023-12-07:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-11-02:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-10-12:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-08-08:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-25:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-19:
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-11:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-04:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-02-14:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-02-08:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    14.8 Thousand total shares from 4 transactions

    Exercise Derivative Conversion (M)

    13.5 Thousand total shares from 2 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    SCULLY ROBERT W

    • Director
    7,590 2023-12-07 3

    LAGANO ROXANNE EXECUTIVE VICE PRESIDENT

    • Officer
    22,711 2023-11-29 14

    PECK KRISTIN C CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    57,639 2023-11-21 10

    ASHTON NICHOLAS EXECUTIVE VICE PRESIDENT

    • Officer
    235 2023-10-30 2

    JOSEPH WETTENY CHIEF FINANCIAL OFFICER

    • Officer
    0 2023-10-06 6

    CHEN HEIDI C. EXECUTIVE VICE PRESIDENT

    • Officer
    0 2023-10-06 9

    MAMILLI WAFAA EXECUTIVE VICE PRESIDENT

    • Officer
    0 2023-10-06 7

    FERRAN ASTORGA JEANNETTE EXECUTIVE VICE PRESIDENT

    • Officer
    0 2023-10-06 6

    POLZER ROBERT J EXECUTIVE VICE PRESIDENT

    • Officer
    0 2023-10-06 8

    DRISCOLL RIMMA EXECUTIVE VICE PRESIDENT

    • Officer
    0 2023-10-06 6

    BANQUE SORIA ESTER EXECUTIVE VICE PRESIDENT

    • Officer
    0 2023-07-31 2

    NORDEN GREGORY

    • Director
    10,556 2023-05-15 4

    MCCALLISTER MICHAEL B

    • Director
    23,654 2023-02-11 2

    DAMELIO FRANK A

    • Director
    0 2023-02-11 2

    PARENT LOUISE M

    • Director
    11,902 2023-02-11 2

    BISARO PAUL

    • Director
    18,826 2023-02-11 2

    RHODES LINDA

    • Director
    6,987 2023-02-11 2

    SANJAY KHOSLA

    • Director
    0 2023-02-11 2

    REED WILLIE M

    • Director
    8,408 2023-02-11 2

    BRANNAN JAMIE EXECUTIVE VICE PRESIDENT

    • Officer
    1,488 2023-02-11 2

    LEATHERBERRY ANTOINETTE RENEE

    • Director
    0 2023-02-08 1

    BROADHURST VANESSA

    • Director
    0 2023-02-08 1

    DAVID GLENN EXECUTIVE VICE PRESIDENT

    • Officer
    24,795 2023-01-13 1

    NAYAK ABHAY U EXECUTIVE VICE PRESIDENT

    • Officer
    1,441 2022-10-07 0

    BETTINGTON TIMOTHY J EXECUTIVE VICE PRESIDENT

    • Officer
    3,370 2022-10-07 0

    TRAWICKI ROMAN EXECUTIVE VICE PRESIDENT

    • Officer
    42,159 2022-03-16 0

    KNUPP CATHERINE A. EXECUTIVE VICE PRESIDENT

    • Officer
    43,642 2021-11-10 0

    PUDLOSKI SHERRY N EXECUTIVE VICE PRESIDENT

    • Officer
    243 2021-10-08 0

    STEERE WILLIAM C JR

    • Director
    No longer subject to file 2021-05-20 0

    ALAIX JUAN RAMON

    • Director
    No longer subject to file 2021-05-20 0

    KELLY ROBERT EDWARD EXECUTIVE VICE PRESIDENT

    • Officer
    54,436 2021-05-03 0

    MCFARLAND JAMES MICHAEL EXECUTIVE VICE PRESIDENT

    • Officer
    3,062 2021-04-09 0

    LEWIS CLINTON A. JR. EXECUTIVE VICE PRESIDENT

    • Officer
    27,904 2019-12-16 0

    FENTON ANDREW EXECUTIVE VICE PRESIDENT

    • Officer
    23,073 2019-12-06 0

    BERNAL ALEJANDRO EXECUTIVE VICE PRESIDENT

    • Officer
    No longer subject to file 2018-02-27 0

    HERENDEEN PAUL EXEC. V.P. AND CFO

    • Officer
    0 2016-07-19 0

    PERSHING SQUARE CAPITAL MANAGEMENT, L.P.

    PS MANAGEMENT GP, LLC

    ACKMAN WILLIAM A

    • SEE FOOTNOTE (4).SEE FOOTNOTE (4).SEE FOOTNOTE (4).
    No longer subject to file 2016-05-12 0

    DOYLE WILLIAM F

    • SEE FOOTNOTE (2).
    No longer subject to file 2016-05-12 0

    BEATY SANDRA J. EXECUTIVE VICE PRESIDENT

    • Officer
    0 2015-04-30 0

    LEE JOYCE J. EXECUTIVE VICE PRESIDENT

    • Officer
    0 2015-04-09 0

    WEISKOPF STEFAN EXECUTIVE VICE PRESIDENT

    • Officer
    0 2015-02-27 0

    PASSOV RICHARD A.

    • FORMER EVP AND CFO
    0 2014-07-15 0

    PFIZER INC

    • 10% Owner
    No longer subject to file 2013-06-24 0

    GERMANO GENO J

    • Director
    5,000 2013-02-06 0

    GIORDANO DOUGLAS E.

    • Director
    5,000 2013-02-06 0

    SCHULMAN AMY W

    • Director
    5,000 2013-02-06 0

    HILL CHARLES H

    • Director
    5,000 2013-02-06 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    SCULLY ROBERT W - Director

    2023-12-08 16:31:03 -0500 2023-12-07 G 10,589 d 0 direct

    LAGANO ROXANNE - Officer EXECUTIVE VICE PRESIDENT

    2023-11-30 16:34:19 -0500 2023-11-29 G 750 d 21,915 direct 1.6692 3.0536 3.0536 6 0.0 1

    PECK KRISTIN C - Director - Officer CHIEF EXECUTIVE OFFICER

    2023-11-21 16:41:47 -0500 2023-11-21 S 5,040 $176.45 d 64,803 direct yes 0.4795 -1.4943 0.4795 2 -1.9849 5

    PECK KRISTIN C - Director - Officer CHIEF EXECUTIVE OFFICER

    2023-11-21 16:41:47 -0500 2023-11-21 S 7,960 $177.08 d 56,843 direct yes 0.4795 -1.4943 0.4795 2 -1.9849 5

    PECK KRISTIN C - Director - Officer CHIEF EXECUTIVE OFFICER

    2023-11-21 16:41:47 -0500 2023-11-21 M 13,000 $46.09 a 69,843 direct yes 0.4795 -1.4943 0.4795 2 -1.9849 5

    PECK KRISTIN C - Director - Officer CHIEF EXECUTIVE OFFICER

    2023-11-21 16:41:47 -0500 2023-11-21 M 13,000 d 283,014 direct yes

    LAGANO ROXANNE - Officer EXECUTIVE VICE PRESIDENT

    2023-11-20 16:45:51 -0500 2023-11-17 S 923 $177.46 d 22,665 direct yes 0.3469 -1.6449 0.8281 3 -1.6449 6

    ASHTON NICHOLAS - Officer EXECUTIVE VICE PRESIDENT

    2023-10-31 17:10:26 -0400 2023-10-30 F 257 $157.00 d 235 direct 6.2533 12.8302 12.8302 6 0.0 1

    ASHTON NICHOLAS - Officer EXECUTIVE VICE PRESIDENT

    2023-10-31 17:10:26 -0400 2023-10-30 M 492 a 492 direct 6.2533 12.8302 12.8302 6 0.0 1

    ASHTON NICHOLAS - Officer EXECUTIVE VICE PRESIDENT

    2023-10-31 17:10:26 -0400 2023-10-30 M 492 d 356 direct

    LAGANO ROXANNE - Officer EXECUTIVE VICE PRESIDENT

    2023-10-19 16:07:58 -0400 2023-10-18 S 923 $172.92 d 23,588 direct yes -0.3531 -6.6192 9.2567 9.2567 31 -9.1487 9

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    ZOETIS INC ZTS 2023-12-08 22:15:04 UTC 4.9065 0.4135 0
    ZOETIS INC ZTS 2023-12-08 21:45:04 UTC 4.9065 0.4135 0
    ZOETIS INC ZTS 2023-12-08 21:15:04 UTC 4.9065 0.4135 0
    ZOETIS INC ZTS 2023-12-08 20:45:04 UTC 4.9065 0.4135 0
    ZOETIS INC ZTS 2023-12-08 20:15:07 UTC 4.9065 0.4135 0
    ZOETIS INC ZTS 2023-12-08 19:45:04 UTC 4.9065 0.4135 0
    ZOETIS INC ZTS 2023-12-08 19:15:03 UTC 4.9065 0.4135 0
    ZOETIS INC ZTS 2023-12-08 18:45:03 UTC 4.9065 0.4135 0
    ZOETIS INC ZTS 2023-12-08 18:15:04 UTC 4.9065 0.4135 0
    ZOETIS INC ZTS 2023-12-08 17:45:03 UTC 4.9065 0.4135 0
    ZOETIS INC ZTS 2023-12-08 17:15:03 UTC 4.9065 0.4135 0
    ZOETIS INC ZTS 2023-12-08 16:45:05 UTC 4.9065 0.4135 0
    ZOETIS INC ZTS 2023-12-08 16:15:04 UTC 4.9065 0.4135 0
    ZOETIS INC ZTS 2023-12-08 15:45:04 UTC 4.9101 0.4099 0
    ZOETIS INC ZTS 2023-12-08 15:15:04 UTC 4.9101 0.4099 0
    ZOETIS INC ZTS 2023-12-08 14:45:04 UTC 4.9119 0.4081 0
    ZOETIS INC ZTS 2023-12-08 14:15:03 UTC 4.9119 0.4081 0
    ZOETIS INC ZTS 2023-12-08 13:45:03 UTC 4.9119 0.4081 0
    ZOETIS INC ZTS 2023-12-08 13:15:04 UTC 4.9119 0.4081 0
    ZOETIS INC ZTS 2023-12-08 12:45:05 UTC 4.9119 0.4081 0

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    AGF Investments Trust- AGFIQ U.S. Market Neutral Value Fund ZTS -19.0 shares, $-3142.03 2020-09-30 N-PORT
    Ultimus Managers Trust- WAYCROSS LONG/SHORT EQUITY FUND ZTS -6450.0 shares, $-1032645.0 2020-08-31 N-PORT
    FundVantage Trust- Gotham Absolute 500 Core Fund ZTS -26.0 shares, $-3059.94 2020-03-31 N-PORT
    FundVantage Trust- Gotham Master Neutral Fund ZTS -2.0 shares, $-330.74 2020-09-30 N-PORT
    Nuveen Investment Trust- Nuveen Equity Market Neutral Fund ZTS -1300.0 shares, $-229684.0 2021-05-31 N-PORT
    BNY Mellon Advantage Funds, Inc.- BNY Mellon Global Real Return Fund ZTS -632.0 shares, $-44240.0 2023-07-31 N-PORT
    Alger Funds II- Alger Dynamic Opportunities Fund ZTS -4073.0 shares, $-766090.57 2023-07-31 N-PORT
    JPMorgan Trust I- JPMorgan Research Market Neutral Fund ZTS -2230.0 shares, $-419440.7 2023-07-31 N-PORT
    Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund ZTS -100.0 shares, $-17398.0 2023-09-30 N-PORT
    AQR Funds- AQR Alternative Risk Premia Fund ZTS -2682.0 shares, $-466614.36 2023-09-30 N-PORT
    FundVantage Trust- Gotham Enhanced 500 Plus Fund ZTS -95.0 shares, $-16528.1 2023-09-29 N-PORT
    FundVantage Trust- Gotham Hedged Core Fund ZTS -68.0 shares, $-11830.64 2023-09-29 N-PORT

    Congressional Transactions Past 6-Months

    To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***
    Congress Person Party Chamber Filing Filing Date Transaction Date Security Type Owner Transaction Amount
    Hon. Markwayne Mullin republican Senate Filing 2023-11-01 2023-10-03 JT P $1,001-$15,000
    Hon. Greg Stanton House Filing 2023-10-26 2023-10-24 SP S $1,001-$15,000
    Hon. Greg Stanton House Filing 2023-10-21 2023-09-26 SP P $1,001-$15,000
    Hon. Markwayne Mullin republican Senate Filing 2023-10-12 2023-09-13 JT P $15,001-$50,000
    Hon. Robert J. Wittman republican House Filing 2023-09-26 2023-07-21 P $1,001-$15,000
    senator Daniel S Sullivan republican Senate Filing 2023-09-22 2023-08-22 JT S $1,001-$15,000
    senator Daniel S Sullivan republican Senate Filing 2023-09-18 2023-08-22 JT S $1,001-$15,000
    Hon. Daniel Goldman House Filing 2023-08-07 2023-07-14 S $1,001-$15,000
    senator Daniel S Sullivan republican Senate Filing 2023-07-26 2022-11-30 JT P $1,001-$15,000
    WhaleWisdom Logo

    Elevate your investments